[go: up one dir, main page]

NL8105791A - Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen. - Google Patents

Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen. Download PDF

Info

Publication number
NL8105791A
NL8105791A NL8105791A NL8105791A NL8105791A NL 8105791 A NL8105791 A NL 8105791A NL 8105791 A NL8105791 A NL 8105791A NL 8105791 A NL8105791 A NL 8105791A NL 8105791 A NL8105791 A NL 8105791A
Authority
NL
Netherlands
Prior art keywords
compounds
preparation
therapeutic use
novel heterocyclic
heterocyclic aminoalkyl
Prior art date
Application number
NL8105791A
Other languages
English (en)
Dutch (nl)
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8027252A external-priority patent/FR2496653A1/fr
Priority claimed from FR8123304A external-priority patent/FR2518087A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of NL8105791A publication Critical patent/NL8105791A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8105791A 1980-12-22 1981-12-22 Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen. NL8105791A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8027252A FR2496653A1 (fr) 1980-12-22 1980-12-22 Nouveaux derives aminoalcoyl heterocycliques, leurs procedes de preparation et leur application en therapeutique
FR8123304A FR2518087A2 (en) 1981-12-14 1981-12-14 Aminoalkyl di:hydro-naphthalene, isoquinoline and benzoxazepine cpds. - useful as analgesics and antidepressants

Publications (1)

Publication Number Publication Date
NL8105791A true NL8105791A (nl) 1982-07-16

Family

ID=26222136

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8105791A NL8105791A (nl) 1980-12-22 1981-12-22 Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen.

Country Status (11)

Country Link
US (3) US4386090A (xx)
AU (1) AU7875781A (xx)
CA (1) CA1181748A (xx)
DE (1) DE3150876A1 (xx)
ES (3) ES8306093A1 (xx)
GB (2) GB2091250B (xx)
GR (1) GR78081B (xx)
IT (1) IT1168074B (xx)
LU (1) LU83850A1 (xx)
NL (1) NL8105791A (xx)
SE (1) SE8107537L (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
FR2544718B1 (fr) * 1983-04-21 1985-12-20 Hexachimie Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
US4745222A (en) * 1983-05-25 1988-05-17 Merrell Dow Pharmaceuticals Inc. Novel aryloxycycloalkanolaminoalkylene aryl ketones
DE3413897A1 (de) * 1984-04-13 1985-10-17 Bayer Ag, 5090 Leverkusen (beta)-naphthylalkylamine
EP0261842B1 (en) * 1986-09-17 1990-11-22 Dr. Lo. Zambeletti S.p.A. N1-acylated-(1-(phenyl or benzyl))-1,2-ethylene diamines
ZA885824B (en) * 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
US5561152A (en) * 1987-08-14 1996-10-01 Merrell Pharmaceuticals Inc. Antidepressants
US5149714A (en) * 1987-08-14 1992-09-22 Merrell Dow Pharmaceuticals Inc. Antidepressants
US5229414A (en) * 1988-01-21 1993-07-20 Imperial Chemical Industries Plc Diamine compounds
US5071845A (en) * 1988-12-28 1991-12-10 Suntory Limited Benzoxazepine derivative
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
IT1303737B1 (it) * 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
WO2002057215A2 (en) * 2001-01-16 2002-07-25 Theravance, Inc. Sodium channel modulators
WO2003000181A2 (en) * 2001-06-20 2003-01-03 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment of diabetes
WO2003000180A2 (en) * 2001-06-20 2003-01-03 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment of diabetes
EP1471054B1 (en) * 2002-01-11 2009-07-01 Daiichi Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
ATE451369T1 (de) * 2002-07-15 2009-12-15 Merck & Co Inc Piperidinopyrimidindipeptidylpeptidaseinhibitor n zur behandlung von diabetes
AU2003275404A1 (en) * 2002-10-07 2004-05-04 Merck & Co., Inc. Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors
BR0315796A (pt) * 2002-11-07 2005-09-13 Merck & Co Inc Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
CA2508487A1 (en) * 2002-12-04 2004-06-17 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
AU2003297219A1 (en) * 2002-12-20 2004-07-22 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
JP4564952B2 (ja) * 2003-01-17 2010-10-20 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての３−アミノ−４−フェニルブタン酸誘導体
EP1592689A4 (en) * 2003-01-31 2008-12-24 Merck & Co Inc 3-AMINO-4-PHENYLBUTANEAN DERIVATIVES AS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
DE602004023932D1 (de) * 2003-05-14 2009-12-17 Merck & Co Inc 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
AU2004247068A1 (en) * 2003-06-06 2004-12-23 Merck & Co., Inc. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
JP4579239B2 (ja) * 2003-06-17 2010-11-10 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病の治療または予防するためのジペプチジルペプチダーゼ阻害剤としてのシクロヘキシルグリシン誘導体
US7259160B2 (en) * 2003-07-31 2007-08-21 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
ATE455088T1 (de) * 2003-09-18 2010-01-15 Takasago Perfumery Co Ltd Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
CA2541212A1 (en) * 2003-11-04 2005-05-19 Wallace T. Ashton Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물
CN1950349A (zh) * 2004-05-04 2007-04-18 默克公司 作为用于治疗或预防糖尿病的二肽基肽酶－ⅳ抑制剂的1,2,4－噁二唑衍生物
US7504413B2 (en) * 2004-05-06 2009-03-17 Cytokinetics, Inc. N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
US7795448B2 (en) * 2004-05-06 2010-09-14 Cytokinetics, Incorporated Imidazoyl-benzamide anti-cancer agents
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
EP1604662A1 (en) * 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
EP1942899A4 (en) * 2005-11-02 2010-04-28 Cytokinetics Inc INHIBITORS OF MITOTIC KINESINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2168929A (en) * 1936-12-12 1939-08-08 Winthrop Chem Co Inc Isoquinoline compounds and derivatives thereof
US3663608A (en) * 1969-12-10 1972-05-16 Bristol Myers Co 1-phenyl-3-aminoalkyl-1,2,3,4-tetrahydronaphthalenes and the salts thereof
US3704328A (en) * 1970-01-21 1972-11-28 James S Kaltenbronn 4- and 5-aryl-1-naphthaleneethanol compounds
US3663627A (en) * 1970-06-01 1972-05-16 Bristol Myers Co 1-indanmethanols
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
US4022791A (en) * 1975-06-03 1977-05-10 Pfizer Inc. 2-Aminomethyl-3,4-dihydronaphthalenes

Also Published As

Publication number Publication date
ES8400093A1 (es) 1983-11-01
LU83850A1 (fr) 1983-09-02
IT1168074B (it) 1987-05-20
US4504663A (en) 1985-03-12
IT8125722A0 (it) 1981-12-21
ES8400388A1 (es) 1983-11-01
GB8409163D0 (en) 1984-05-16
GR78081B (xx) 1984-09-26
SE8107537L (sv) 1982-06-23
ES518693A0 (es) 1983-11-01
ES518692A0 (es) 1983-11-01
CA1181748A (en) 1985-01-29
US4386090A (en) 1983-05-31
US4431851A (en) 1984-02-14
GB2137992A (en) 1984-10-17
DE3150876A1 (de) 1982-07-29
ES508670A0 (es) 1983-06-01
AU7875781A (en) 1982-07-01
GB2091250B (en) 1984-11-14
GB2137992B (en) 1985-05-09
ES8306093A1 (es) 1983-06-01
GB2091250A (en) 1982-07-28

Similar Documents

Publication Publication Date Title
NL8105791A (nl) Nieuwe heterocyclische aminoalkylverbindingen, werkwijze voor hun bereiding alsmede de therapeutische toepassing van deze verbindingen.
NO154764C (no) Gel for behandling av underjordiske formasjoner.
NL189757C (nl) Werkwijze voor het continu bereiden van nitrobenzeen.
NL930056I2 (nl) Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan.
NL7900871A (nl) Werkwijze voor de therapeutische behandeling van hyperlipidemie en hyperlipiproteinemie.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
JPS56103113A (en) Drug for shock treatment
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NL191149C (nl) Werkwijze voor de bereiding van 3-trifluormethylpyridinederivaten.
HU178841B (en) Cattle-leader for the prophylactic or therapeutic treatment of cattle
TR20880A (tr) Akrilonitrilin aritilmasi
NL7811823A (nl) Nieuwe oximen werkwijze voor de bereiding van oxyderen en oximen bevattend therapeutisch preparaat.
FI800089A7 (fi) Viherkaihin hoitoon tarkoitettuja valmisteita.
NL7903853A (nl) Nieuwe derivaten van 4-amino-2-piperidinochinazoline en werkwijzen voor hun bereiding en toepassing.
NL7805849A (nl) Nieuwe benzodiazepin-6-on derivaten en werkwijzen voor hun bereiding en toepassing.
NL7803896A (nl) Nieuwe pyrrolochinoxalineverbindingen, werkwijze voor hun bereiding en geneesmiddelen.
NL7801887A (nl) Nieuwe 20,21-dinoreburnamenine-verbindingen, werkwijze voor hun bereiding en farmaceutische preparaten.
NL7808276A (nl) Nieuwe 1,3-difenoxypropaan-2-on derivaten, werkwijze voor het bereiden daarvan alsmede voornoemde derivaten bevattende geneesmiddelen.
GB2044311B (en) Process for the treatment of wood
NO803403L (no) Anordning for behandling av virke.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NL7800001A (nl) Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten.
NL7803995A (nl) Werkwijze voor de bereiding van pyridoxine.
NL7808944A (nl) Werkwijze voor de bereiding van heterocyclische zuur- stofverbindingen.
NL7606238A (nl) Werkwijze voor de bereiding van nieuwe cyclo- propanolderivaten, alsmede de toepassing ervan.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed